The Intelligence Layer for Predictive, Preventative Healthcare
Vitaspan turns fragmented medical records into organised, AI-ready data. This helps clinicians catch problems earlier, make better decisions and prevent disease before it strikes. We’re moving healthcare from reacting to predicting, because lives depend on it.
Reactive healthcare is failing us
The Problem with Today’s Healthcare is That It Waits
70% of deaths in the US, 40% in the UK and 25% in Europe, are due to chronic, preventable diseases.
The Cost of Waiting is Too High
The total economic impact of chronic diseases worldwide is estimated to be $47 trillion in 2030. 2024 World GDP was approximately $106 trillion.
Clinicians are stuck managing data instead of managing health
Fragmented, siloed medical data means clinicians spend 40% of their time not treating patients, but grappling with information.
Prevention is at least 4x more cost-effective than cure, and leads to better health outcomes, but the healthcare system isn’t built for it.
Vitaspan is an AI-driven platform that unifies scattered patient data to deliver real-time insights and predictive health alerts. It helps individuals make smarter choices and care teams act early – reducing risk, lowering costs and improving outcomes through proactive, personalised care.
Ingest & Structure
Medical Data
Enrich & Activate
with AI
Deliver Value Across
the Ecosystem
Vitaspan integrates with electronic health records, labs, clinics, and insurers - ingesting fragmented medical data across systems. That data is then cleaned, normalised, and mapped to clinical taxonomies.
Our AI transforms data into predictive insights, empowering clinicians and individuals with early warnings and actionable health plans, all clinically validated.
From healthcare, through health pricing, to health marketplaces, Vitaspan’s structured data infrastructure powers predictive analytics, risk stratification, and innovative revenue streams, transforming the quality and delivery of healthcare and its economics.
Proprietary AI that turns fragmented health data into life-saving insights
Prevents Disease Before It Happens
Shifts healthcare from reactive treatment to predictive prevention. Healthier populations, lower burden on care systems and measurable reductions in avoidable mortality.
Frees Up Clinician Capacity at Scale
Structured and streamlined medical data allows clinicians to treat up to 60% more patients with higher accuracy, reducing clinician burnout, and enabling clinicians to focus on patient relationships.
Enables Actionable, AI-Driven Insights
Vitaspan transforms fragmented health records into usable AI-ready data enabling earlier, smarter and more personalised care.
Unlocks New Revenue Streams Across Healthcare and Insurance
Vitaspan transforms clinical insight into financial leverage, driving new revenue streams in health scoring, digital underwriting and connected care marketplaces.
Clinicians get a complete view of each patient in one place, which means, no more digging for data.
.webp)
That means more time for care, better decisions and stronger patient relationships.
“Partnering with Vitaspan aligns perfectly with our mission to deliver proactive, predictive care at scale. Vitaspan’s focus on clinical utility, structured health data, and regulatory compliance makes them the ideal partner to amplify the reach and effectiveness of our AI algorithms. Together, we are committed to reducing disease burdens and enhancing health outcomes in healthcare systems facing increasing pressure.”
We’re in active talks with a multitude of clinics, concierge groups, and digital health providers across the US, Europe, MENA, and Asia — all aiming to unlock health data and power AI to shift care from reactive to predictive.
Leading consultants in private healthcare and diagnostics aren’t just endorsing Vitaspan, They’re actively introducing peers, and investors. Their conviction positions us as the clinical backbone of preventative care, not another front-end app.
Collaboration signed to deploy predictive AI models within clinical environments, validating our data infrastructure layer on a global scale.
Finalising agreements to launch in full clinical environments, with pilots set to commence.
Our next milestone expands Vitaspan’s reach from clinical insight to commercial impact, unlocking use cases in health scoring, insurance, and digital underwriting.
Led by visionaries. Backed by a world-class team of experts.
MARK JACKSON
ZAFAR KARIM
Healthcare has to undergo a critical shift from reactive treatment to proactive prevention. Current healthcare spending has become unsustainable: $4.9 trillion in the US, €1.6 trillion in Europe, and £292 billion in the UK. The market has to, and is responding.
Invest in the Future of Preventative Healthcare
We’re seeking visionary partners to help scale Vitaspan and transform the way the world manages health.
MARK JACKSON
Mark is an exceptionally driven and strategically minded leader, recognised for transforming businesses in highly regulated sectors across multinational corporations and innovative startups in the UK, USA, and Middle East. Before founding Vitaspan, he served as CEO of Lifelines Neuro, an FDA-regulated med-tech company, where he led a pivotal transformation, shifting the business to a recurring SaaS revenue model, dramatically improving profitability, and achieving sustained EBITDA growth.
Mark previously held senior roles at Thomson Reuters, managing strategic global partnerships with Microsoft, Oracle, and IBM, and driving commercial excellence across high-growth markets. His proven capability in scaling businesses, deep expertise in SaaS models, and strategic acumen uniquely equip him to lead Vitaspan’s ambitious mission: revolutionising healthcare by shifting the paradigm from reactive treatment to proactive, predictive prevention.
Zafar Karim
Zafar is a seasoned entrepreneur and former investment banker with 30+ years of experience building, backing, and scaling platform ventures across fintech, logistics & distribution, cybersecurity, and now healthtech, recognising “where the puck is going”. He began his career at Salomon Brothers and Rothschild, advising on over £1bn of global transactions.
He holds an MA in Economics from Cambridge and completed executive programmes in AI and Blockchain Strategy at Oxford Saïd.